Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule
NCT03785574Recruiting
- Sponsor
- Women's Hospital, Zhejiang University School of Medicine
- Start
- Dec 2018
- Primary completion
- Sep 2030
- Countries
- 1
01
Overview
Randomised, open-label trial in hydatidiform mole (HM) and gestational trophoblastic neoplasia (GTN) (3 arms), sponsored by Women's Hospital, Zhejiang University School of Medicine. Primary endpoints: Number of chemotherapy cycles to achieve hCG normalization at 120 months and hCG declined to normal spontaneously of group B at 120 months. Started Dec 2018; status: recruiting.
02
Conditions
hydatidiform mole (HM)gestational trophoblastic neoplasia (GTN)
Beyond the preview
Go deeper on NCT03785574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03785574.